#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	15198	16S	1529	1529	100.0	16S.l15.c30.ctg.1	2240	675.0	1	SNP	n	C1184T	0	.	.	1184	1184	C	1554	1554	C	909	C	851	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27800	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3520	786.8	0	.	n	.	0	T695C	SNP	695	695	T	1013	1013	C	833	C,T	778,2	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27800	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3520	786.8	0	.	n	.	0	G1337A	SNP	1337	1337	G	1655	1655	A	965	A	907	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27800	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3520	786.8	0	.	n	.	0	T1971C	SNP	1971	1971	T	2289	2289	C	878	C	823	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27800	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3520	786.8	1	SNP	n	A2045G	0	.	.	2045	2045	A	2363	2363	A	865	A,C	812,1	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27800	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3520	786.8	1	SNP	n	C2597T	0	.	.	2597	2597	C	2915	2915	C	846	C,A	811,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_P_01364c	folP.WHO_P_01364c	1	1	27	2160	folP	852	852	100.0	folP.l15.c17.ctg.1	1483	144.7	1	SNP	p	R228S	1	.	.	682	684	AGC	934	936	AGC	236;238;235	A;G;C	232;234;230	folP.WHO_P_01364c:1:1:R228S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5258	gyrA	2751	2751	99.85	gyrA.l6.c17.ctg.1	3456	151.5	1	SNP	p	S91F	0	.	.	271	273	TCC	668	670	TCC	171;173;174	T;C;C	159;161;160	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5258	gyrA	2751	2751	99.85	gyrA.l6.c17.ctg.1	3456	151.5	1	SNP	p	D95N	0	.	.	283	285	GAC	680	682	GAC	172;174;174	G;A;C	159;162;163	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5258	gyrA	2751	2751	99.85	gyrA.l6.c17.ctg.1	3456	151.5	1	SNP	p	D95G	0	.	.	283	285	GAC	680	682	GAC	172;174;174	G;A;C	159;162;163	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_G_01393	mtrR.WHO_G_01393	1	1	539	1654	mtrR	633	633	99.21	mtrR.l15.c4.ctg.1	1358	121.1	0	.	p	.	0	A39T	NONSYN	115	117	GCC	510	512	ACC	209;207;207	A;C;C	185;190;189	.	.
mtrR.WHO_G_01393	mtrR.WHO_G_01393	1	1	539	1654	mtrR	633	633	99.21	mtrR.l15.c4.ctg.1	1358	121.1	0	.	p	.	0	R44H	NONSYN	130	132	CGC	525	527	CAC	199;202;201	C;A;C	182;180;186	.	.
mtrR.WHO_G_01393	mtrR.WHO_G_01393	1	1	539	1654	mtrR	633	633	99.21	mtrR.l15.c4.ctg.1	1358	121.1	0	.	p	.	0	Y105H	NONSYN	313	315	TAC	708	710	CAC	225;225;226	C;A;C	214;214;216	.	.
mtrR.WHO_G_01393	mtrR.WHO_G_01393	1	1	539	1654	mtrR	633	633	99.21	mtrR.l15.c4.ctg.1	1358	121.1	1	SNP	p	G45D	0	.	.	133	135	GGC	528	530	GGC	203;201;202	G;G;C	185;188;186	mtrR.WHO_G_01393:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	904	mtrR_promoter	250	250	100.0	mtrR_promoter.l15.c4.ctg.1	1170	77.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	5498	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2964	185.1	1	SNP	p	D86N	0	.	.	256	258	GAC	609	611	GAC	238;234;235	G;A;C	228;225;224	parC.WHO_P_00203c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	5498	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2964	185.1	1	SNP	p	S87W	0	.	.	259	261	AGT	612	614	AGT	236;236;233	A;G;T,C	225;228;220,1	parC.WHO_P_00203c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	5498	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2964	185.1	1	SNP	p	S87I	0	.	.	259	261	AGT	612	614	AGT	236;236;233	A;G;T,C	225;228;220,1	parC.WHO_P_00203c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	5498	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2964	185.1	1	SNP	p	S87R	0	.	.	259	261	AGT	612	614	AGT	236;236;233	A;G;T,C	225;228;220,1	parC.WHO_P_00203c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	5498	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2964	185.1	1	SNP	p	S88P	0	.	.	262	264	TCC	615	617	TCC	236;237;238	T;C;C	224;224;226	parC.WHO_P_00203c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4416	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2837	155.1	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1624	1626	GGC	210;211;210	G;G;C	199;199;196	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.22.001	penA.22.001	1	1	27	4194	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2449	170.7	1	SNP	p	A311V	0	.	.	931	933	GCA	1264	1266	GCA	210;214;215	G;C,A;A	194;193,1;197	penA.22.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	4194	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2449	170.7	1	SNP	p	I312M	0	.	.	934	936	ATC	1267	1269	ATC	213;212;220	A;T;C	197;196;201	penA.22.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	4194	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2449	170.7	1	SNP	p	V316P	0	.	.	946	948	GTG	1279	1281	GTG	219;217;217	G;T;G	199;197;196	penA.22.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	4194	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2449	170.7	1	SNP	p	V316T	0	.	.	946	948	GTG	1279	1281	GTG	219;217;217	G;T;G	199;197;196	penA.22.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	4194	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2449	170.7	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1783	1785	ACC	222;220;220	A;C;C	199;203;207	penA.22.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	4194	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2449	170.7	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1837	1839	GCG	210;210;214	G;C,T;G	190;180,1;185	penA.22.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	4194	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2449	170.7	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1837	1839	GCG	210;210;214	G;C,T;G	190;180,1;185	penA.22.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	4194	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2449	170.7	1	SNP	p	G543S	0	.	.	1627	1629	GGT	1960	1962	GGT	178;177;178	G;G;T	167;164;164	penA.22.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	4194	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2449	170.7	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1969	1971	GGC	178;178;181	G;G;C	164;164;164	penA.22.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	4194	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2449	170.7	1	SNP	p	P552S	0	.	.	1654	1656	CCG	1987	1989	CCG	169;169;170	C;C;G	130;144;141	penA.22.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_F_00106	ponA.WHO_F_00106	1	1	27	5946	ponA	2397	2397	99.96	ponA.l15.c30.ctg.1	3287	180.5	1	SNP	p	L421P	0	.	.	1261	1263	CTG	1775	1777	CTG	216;215;214	C,A;T;G	197,1;199;200	ponA.WHO_F_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2372	porA	1146	1146	99.83	porA.l15.c17.ctg.1	1857	127.0	0	.	p	.	0	M83fs	FSHIFT	247	247	A	524	524	C	162	C,A	143,1	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3064	porB1b	1038	1038	99.33	porB1b.l6.c4.ctg.1	1580	193.0	0	.	p	.	0	I45V	NONSYN	133	135	ATT	457	459	GTT	242;242;240	G;T;T	231;229;225	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3064	porB1b	1038	1038	99.33	porB1b.l6.c4.ctg.1	1580	193.0	0	.	p	.	0	I75V	NONSYN	223	225	ATT	547	549	GTT	240;242;243	G;T;T	225;214;226	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3064	porB1b	1038	1038	99.33	porB1b.l6.c4.ctg.1	1580	193.0	0	.	p	.	0	S89T	NONSYN	265	267	AGC	589	591	ACC	244;244;243	A;C;C,G	209;221;219,1	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3064	porB1b	1038	1038	99.33	porB1b.l6.c4.ctg.1	1580	193.0	0	.	p	.	0	I98V	NONSYN	292	294	ATC	616	618	GTC	252;250;248	G;T;C	223;225;226	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3064	porB1b	1038	1038	99.33	porB1b.l6.c4.ctg.1	1580	193.0	0	.	p	.	0	S217G	NONSYN	649	651	AGT	973	975	GGT	255;255;254	G,T;G;T	241,1;244;243	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3064	porB1b	1038	1038	99.33	porB1b.l6.c4.ctg.1	1580	193.0	1	SNP	p	G120K	1	.	.	358	360	AAG	682	684	AAG	248;247;249	A;A;G,T	237;236;236,1	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3064	porB1b	1038	1038	99.33	porB1b.l6.c4.ctg.1	1580	193.0	1	SNP	p	A121N	1	.	.	361	363	AAC	685	687	AAC	250;253;252	A;A;C	239;240;240	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3064	porB1b	1038	1038	99.33	porB1b.l6.c4.ctg.1	1580	193.0	1	SNP	p	N121D	0	.	.	361	363	AAC	685	687	AAC	250;253;252	A;A;C	239;240;240	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	10914	rpoB	4179	4179	100.0	rpoB.l15.c4.ctg.1	4964	219.4	1	SNP	p	H553N	1	.	.	1657	1659	AAT	2069	2071	AAT	219;219;217	A;A;T	203;204;200	rpoB.WHO_M_02157:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1252	rpsJ	312	312	100.0	rpsJ.l15.c17.ctg.1	1147	108.7	1	SNP	p	V57M	1	.	.	169	171	ATG	459	461	ATG	257;256;256	A;T;G	241;243;242	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
